AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
LIDOCAINE HYDROCHLORIDE in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| LOX 2% SOLUTION; INJECTION | 2026/1.2.1/7461 | ARAVAS PHARMACEUTICALS | active | 9 Jun 2031 |
| LIGNOX INJECTABLE; INJECTION | 2005/1.2.1/4366 | INDOCO REMEDIES LTD | active | 10 Dec 2030 |
| CP-LIDOCAINE SOLUTION; INJECTION | 2024/1.2.1/6758 | COSPHARM INVESTMENTS PVT LTD | active | 12 Nov 2029 |
| LIDOCAINE HYDROCHLORIDE SOLUTION; INJECTION | 2017/1.2.1/5419 | LINCOLN PHARMACEUTICALS LIMITED | active | 31 Dec 2027 |
| LIDOCAINE HYDROCHLORIDE SOLUTION | 2017/1.2.2/5471 | AMANTA HEALTHCARE LTD | active | 31 Dec 2027 |
LIDOCAINE HYDROCHLORIDE — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing LIDOCAINE HYDROCHLORIDE, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track LIDOCAINE HYDROCHLORIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.